跳至主要内容
临床试验/NCT07537153
NCT07537153招募中不适用

Genicular Artery Embolization for Patients With Mild-To-Moderate Knee Osteoarthritis

Northwestern University1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2026年7月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
15
试验地点
1

研究概览

简要总结

Patients will be asked to take part in this research study because they have mild-to-moderate knee osteoarthritis (OA) and were referred clinically for a procedure called Genicular Artery Embolization (GAE). Osteoarthritis is the most common form of arthritis. It occurs when the protective cartilage that cushions the ends of the bones wears down over time. The symptoms of OA include pain or aching, stiffness, decreased range of motion, and swelling. The purpose of this study is to evaluate the safety and effectiveness of GAE for the treatment of knee pain attributed to OA.

Research participants will be in this research study for about 3 years. The study includes a screening visit, GAE procedure, and six follow-up visits.

At the screening visit, a review of their medical history, demographics, and medications will be collected; physical examination will be completed; knee x-ray will be done; and two questionnaires on your knee pain will be administered. The GAE procedure will involve receiving sedation or medication to help them relax, lidocaine injected under the skin in the area of the body where catheters will be inserted into one of your arteries and then using x-ray, a catheter will be directed to the arteries supplying the lining of the knee. Then tiny microspheres will be injected into the artery to decrease the blood supply to this knee joint tissue.

The follow-up visits up to 12 months will include a focused physical examination of the treated knee, documentation of medications, and two questionnaires will be administered. The follow-up visits at year 2 and 3 will include documentation of medications and any new treatments for OA as well as completion of two questionnaires. Follow-up visits maybe conducted in clinic or remotely.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 40-80 years
  • Mild-to-moderate knee OA as determined by radiographs demonstrating Kellgren- Lawrence grade 2-3
  • Self-reported pain of at least 5/10 VAS questionnaire
  • Failure of conservative therapy, such as pain medications, for at least 3 months
  • Patient must understand and sign the informed consent
  • Patient can comply with the proposed follow-up schedule
  • Patient can follow the post-operative management

排除标准

  • History of rheumatoid arthritis
  • Renal insufficiency precluding angiography (GFR < 50 mL/min)
  • Irreversible coagulopathy
  • Previous knee arthroplasty on the intended knee
  • Existing knee joint infection
  • Kellgren-Lawrence grade 1 or 4
  • Severe atherosclerosis as manifest by claudication and/or diminished peripheral pulses
  • Life expectancy < 6 months
  • Infectious arthritis
  • Allergy to iodinated contrast resulting in anaphylaxis
  • Pregnant or interested in becoming pregnant three months from the date of the GAE procedure
  • Involved in litigation or worker's compensation claims

研究组 & 干预措施

GAE Procedure

Experimental

All participants will undergo a procedure called Genicular Artery Embolization (GAE) that will be done to try to reduce the pain in their knees.

干预措施: Embosphere Microspheres (Device)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert Lewandowski

Professor of Radiology, Medicine, and Surgery; Director of Interventional Oncology

Northwestern University

研究点 (1)

Loading locations...

相似试验